To examine if co-culture with stromal cells could compensate to any degree for lack of endogenous Galectin-1 and Galectin-3 in double null mutant cells, we compared the growth and survival of dKO BCP-ALL cells, cultured with and without MEFs during nilotinib treatment. The gene discussed is LGALS3; the disease is acute lymphoblastic leukemia.